On a molecular level, KAN0439834 inhibited the phosphorylation of PI3K/AKT/mTOR/CREB and SRC, both in CLL as well as in pancreatic cancer cells [192,193], and thus blocked major pro-survival pathways induced by ROR1. Here, ROR1 is linked to pancreatic neoplasm.